Future Perspectives to Improve CHA₂DS₂VASc Score: The Role of Left Atrium Remodelling, Inflammation and Genetics in Anticoagulation of Atrial Fibrillation

References

• Lyth J, Svennberg E, Bernfort L, et al. Cost-effectiveness of population screening for atrial fibrillation: the STROKESTOP study. Europ Heart J. 2022;00:1–10.
   Google Scholar
• Boriani G, Laroche C, Diemberger I, et al. Asymptomatic atrial fibrillation: clinical correlates, management, and outcomes in the EORP-AF Pilot General Registry. Am J Med. 2015;128(5):509–18.e2. PMID: 25534423. doi:10.1016/j.amjmed.2014.11.026
   PubMed Web of Science ®Google Scholar
• Lip GYH, Laroche C, Popescu MI, et al. Prognosis and treatment of atrial fibrillation patients by European cardiologists: one year follow-up of the EURObservational research programme-atrial fibrillation general registry pilot phase (EORP-AF Pilot registry). Europ Heart J. 2014;35(47):3365. doi:10.1093/eurheartj/ehu374
   PubMed Web of Science ®Google Scholar
• Boriani G, Laroche C, Diemberger I, et al. Glomerular filtration rate in patients with atrial fibrillation and 1-year outcomes. Sci Rep. 2016;6:30271. doi:10.1038/srep30271
   PubMed Web of Science ®Google Scholar
• Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for cardio-thoracic surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European society of cardiology (ESC) developed with the special contribution of the European heart rhythm association (EHRA) of the ESC. Europ Heart J. 2021;42(5):373–498. doi:10.1093/eurheartj/ehaa612
   PubMed Web of Science ®Google Scholar
• Marston NA, Garfinkel AC, Kamanu FK, et al. A polygenic risk score predicts atrial fibrillation in cardiovascular disease. Europ Heart J. 2023;44(3):221–231. doi:10.1093/eurheartj/ehac460
   PubMed Web of Science ®Google Scholar
• Skrebelyte-Strøm L, Morten Rønning O, DahL FA, Steine K, Kjekshus H. Prediction of occult atrial fibrillation in patients after cryptogenic stroke and transient ischaemic attack: PROACTIA. Europace. 2022;24:1881–1888. doi:10.1093/europace/eu
   PubMed Web of Science ®Google Scholar
• Andrade JG, Deyell MW, Macle L, et al. Healthcare utilization and quality of life for atrial fibrillation burden: the CIRCA-DOSE study. Europ Heart J. 2023;44(9):765–776. doi:10.1093/eurheartj/ehac692
   PubMed Web of Science ®Google Scholar
• Svennberg E, Friberg L, Frykman V, Al-Khalili F, Engdahl J, Rosenqvist M. Clinical outcomes in systematic screening for atrial fibrillation (STROKESTOP): a multicentre, parallel group, unmasked, randomised controlled trial. Lancet. 2021;398(10310):1498–1506. PMID: 34469764. doi:10.1016/S0140-6736(21)01637-8
   PubMed Web of Science ®Google Scholar
• Lowe I. Critique of warfarin dosing: the use of nudging to adjust the load. Academia Letters. 2022;2022:2–8.
   Google Scholar
• Thomas FL. Unresolved issues of anticoagulation in atrial fibrillation: age, BMI, reduced dose, and ethnicity. Europ Heart J. 2019;40:1477–1481. doi:10.1093/eurheartj/ehz302
   PubMed Web of Science ®Google Scholar
• Lee J-D, Kuo Y-W, Lee C-P, Huang Y-C, Lee M, Lee T-H. Development and validation of a novel score for predicting paroxysmal atrial fibrillation in acute ischemic stroke. Int J Environ Res. 2022;19:7277. doi:10.3390/ijerph19127277
   Google Scholar
• Edmiston MK, Lewis WR. Bleeding risk scores in atrial fibrillation: helpful or harmful? J Am Heart Assoc. 2018;7(18):e010582. PMID: 30371216; PMCID: PMC6222951. doi:10.1161/JAHA.118.010582
   PubMed Web of Science ®Google Scholar
• Zheng Y, Li TYW, Goh FQ, et al. Abnormal left atrial strain is associated with eventual diagnosis of atrial fibrillation in patients with embolic stroke of undetermined source. Europ Heart J. 2023;44:ehac779–002. doi:10.1093/eurheartj/ehac779.002
   Web of Science ®Google Scholar
• Hijazi Z, Benz AP, Lindbäck J, et al. Bone morphogenetic protein 10: a novel risk marker of ischaemic stroke in patients with atrial fibrillation. Europ Heart J. 2023;44(3):208–218. doi:10.1093/eurheartj/ehac632
   PubMed Web of Science ®Google Scholar
• De Caterina R, Prisco D, Eikelboom JW. Factor XI inhibitors: cardiovascular perspectives. Europ Heart J. 2023;44(4):280–292. doi:10.1093/eurheartj/ehac464
   PubMed Web of Science ®Google Scholar
• Andreotti F, Geisler T, Collet J-P, et al. Acute, periprocedural and long term antithrombotic therapy in older adults: 2022 Update by the ESC working group on thrombosis. Europ Heart J. 2023;44(4):262–279. doi:10.1093/eurheartj/ehac515
   PubMed Web of Science ®Google Scholar
• Andreotti F, Rocca B, Husted S, et al. Antithrombotic therapy in the elderly: expert position paper of the European society of cardiology working group on thrombosis. Europ Heart J. 2015;36:3238–3249. doi:10.1093/eurheartj/ehv304
   PubMed Web of Science ®Google Scholar
• Pennlert J, Overholser R, Asplund K, et al. Optimal timing of anticoagulant treatment after intracerebral hemorrhage in patients with atrial fibrillation. Stroke. 2016;48:314–320. doi:10.1161/STROKEAHA.116.014643
   PubMed Web of Science ®Google Scholar
• Al-Kaisey AM, Kalman JM. Atrial arrhythmia recurrence post-catheter ablation: when perfect is the enemy of good. Europ Heart J. 2023;44(9):777–779. doi:10.1093/eurheartj/ehac736
   PubMed Web of Science ®Google Scholar
• Vincenti A, Genovesi S, Sonaglioni A, et al. Mechanical atrial recovery after cardioversion in persistent atrial fibrillation evaluated by bidimensional speckle tracking echocardiography. J Cardiovasc Med. 2019;20(11):745–751. PMID: 31483328. doi:10.2459/JCM.0000000000000864
   Google Scholar
• Freeman JV, Varosy P, Price MJ, et al. The NCDR left atrial appendage occlusion registry. J Am Coll Cardiol. 2020;75(13):1503–1518. PMID: 32238316; PMCID: PMC7205034. doi:10.1016/j.jacc.2019.12.040
   PubMed Web of Science ®Google Scholar
• Manjunath CN, Srinivasa KH, Ravindranath KS, et al. Balloon mitral valvotomy in patients with mitral stenosis and left atrial thrombus. Catheter Cardiovasc Interv. 2009;74(4):653–661. PMID: 19777604. doi:10.1002/ccd.22176
   PubMed Web of Science ®Google Scholar
• Sonaglioni A, Vincenti A, Lombardo M, Anzà C. Left atrial cavity thrombus and fatal systemic embolization in a stroke patient with nonvalvular atrial fibrillation: a caveat against left atrial appendage closure for stroke prevention. J Cardiovasc Echogr. 2020;30(1):41–43. PMID: 32766107; PMCID: PMC7307615. doi:10.4103/jcecho.jcecho_46_19
   PubMed Web of Science ®Google Scholar
• Floria M, Radu S, Gosav EM, et al. Left Atrial structural remodelling in non-valvular atrial fibrillation: what have we learnt from CMR? Diagnostics. 2020;10(3):137. PMID: 32131455; PMCID: PMC7151417. doi:10.3390/diagnostics10030137
   Web of Science ®Google Scholar
• Cozma D, Streian CG, Vacarescu C, Mornos C. Back to sinus rhythm from atrial flutter or fibrillation: dabigatran is safe without transoesophageal control. Kardiol Pol. 2016;74(5):425–430. PMID: 26502941. doi:10.5603/KP.a2015.0209
   PubMed Web of Science ®Google Scholar
• Luca CT, Crisan S, Cozma D, et al. Arterial hypertension: individual therapeutic approaches-from DNA sequencing to gender differentiation and new therapeutic targets. Pharmaceutics. 2021;13(6):856. PMID: 34207606; PMCID: PMC8229802. doi:10.3390/pharmaceutics13060856
   PubMed Web of Science ®Google Scholar
• Cozma D, Streian CG, Petrescu L, Mornos C. Subclinical left atrium remodelling in patients with frequent premature ventricular contractions. Kardiol Pol. 2014;72(11):1141–1147. PMID: 25522754. doi:10.5603/KP.a2014.0133
   PubMed Web of Science ®Google Scholar
• Douglas PS, Carabello BA, Lang RM, et al. 2019 ACC/AHA/ASE key data elements and definitions for transthoracic echocardiography: a report of the American college of cardiology/American heart association task force on clinical data standards (writing committee to develop cardiovascular endpoints data standards) and the American society of echocardiography. Circ Cardiovasc Imaging. 2019;12(7):e000027. PMID: 31233331. doi:10.1161/HCI.0000000000000027
   PubMed Web of Science ®Google Scholar
• Birnie D, Hudnall H, Lemke B, et al. Continuous optimization of cardiac resynchronization therapy reduces atrial fibrillation in heart failure patients: results of the adaptive cardiac resynchronization therapy trial. Heart Rhythm. 2017;14(12):1820–1825. PMID: 28893549. doi:10.1016/j.hrthm.2017.08.017
   PubMed Web of Science ®Google Scholar
• Vacarescu C, Luca CT, Feier H, et al. Beta blockers and ivabradine titration according to exercise test in LV only fusion CRT pacing. Diagnostics. 2022;12(5):1096. PMID: 35626251; PMCID: PMC9139204. doi:10.3390/diagnostics12051096
   Web of Science ®Google Scholar
• Goanță EV, Luca CT, Vacarescu C, et al. Non-ischemic super-responders in fusion CRT pacing with normal atrioventricular conduction. Diagnostics. 2022;12(9):2032. PMID: 36140434; PMCID: PMC9497644. doi:10.3390/diagnostics12092032
   Web of Science ®Google Scholar
• Arboix A, Martí L, Dorison S, Sánchez MJ. Bayés syndrome and acute cardioembolic ischemic stroke. World J Clin Cases. 2017;5(3):93–101. PMID: 28352633. doi:10.12998/wjcc.v5.i3.93
   PubMed Web of Science ®Google Scholar
• Guo Y, Lip GY, Apostolakis S. Inflammation in atrial fibrillation. J Am Coll Cardiol. 2012;60(22):2263–2270. PMID: 23194937. doi:10.1016/j.jacc.2012.04.063
   PubMed Web of Science ®Google Scholar
• Nso N, Bookani KR, Metzl M, Radparvar F. Role of inflammation in atrial fibrillation: a comprehensive review of current knowledge. J Arrhythm. 2020;37(1):1–10. PMID: 33664879; PMCID: PMC7896450. doi:10.1002/joa3.12473
   PubMed Web of Science ®Google Scholar
• Schnabel RB, Larson MG, Yamamoto JF, et al. Relation of multiple inflammatory biomarkers to incident atrial fibrillation. Am J Cardiol. 2009;104(1):92–96. doi:10.1016/j.amjcard.2009.02.053
   PubMed Web of Science ®Google Scholar
• Goette A, Honeycutt C, Langberg JJ. Electrical remodeling in atrial fibrillation. Time course and mechanisms. Circulation. 1996;94(11):2968–2974. doi:10.1161/01.CIR.94.11.2968
   PubMed Web of Science ®Google Scholar
• Karam BS, Chavez‐Moreno A, Koh W, Akar JG, Akar FG. Oxidative stress and inflammation as central mediators of atrial fibrillation in obesity and diabetes. Cardiovasc Diabetol. 2017;16(1):1–9. doi:10.1186/s12933-017-0604-9
   PubMedGoogle Scholar
• Korantzopoulos P, Letsas KP, Tse G, Fragakis N, Goudis CA, Liu T. Inflammation and atrial fibrillation: a comprehensive review. J Arrhythm. 2018;34(4):394–401. PMID: 30167010; PMCID: PMC6111477. doi:10.1002/joa3.12077
   PubMed Web of Science ®Google Scholar
• Acampa M, Lazzerini PE, Guideri F, Tassi R, Lo monaco A, Martini G. Inflammation and atrial electrical remodelling in patients with embolic strokes of undetermined source. Heart Lung Circ. 2019;28(6):917–922. PMID: 29887417. doi:10.1016/j.hlc.2018.04.294
   PubMed Web of Science ®Google Scholar
• Lazzerini PE, Laghi-Pasini F, Acampa M, et al. Systemic inflammation rapidly induces reversible atrial electrical remodeling: the role of interleukin-6-mediated changes in connexin expression. J Am Heart Assoc. 2019;8(16):e011006. PMID: 31423933; PMCID: PMC6759884. doi:10.1161/JAHA.118.011006
   PubMed Web of Science ®Google Scholar
• Varghese B, Feldman DI, Chew C, et al. Inflammation, atrial fibrillation, and the potential role for colchicine therapy. Heart Rhythm. 2021;2(3):298–303. PMID: 34337581; PMCID: PMC8322795. doi:10.1016/j.hroo.2021.03.011
   Web of Science ®Google Scholar
• Ang YS, Rajamani S, Haldar SM, Hüser J. A new therapeutic framework for atrial fibrillation drug development. Circ Res. 2020;127(1):184–201. PMID: 32717173. doi:10.1161/CIRCRESAHA.120.316576
   PubMed Web of Science ®Google Scholar
• Roselli C, Rienstra M, Ellinor PT. Genetics of atrial fibrillation in 2020: GWAS, genome sequencing, polygenic risk, and beyond. Circ Res. 2020;127(1):21–33. PMID: 32716721; PMCID: PMC7388073. doi:10.1161/CIRCRESAHA.120.316575
   PubMed Web of Science ®Google Scholar
• Andersen JH, Andreasen L, Olesen MS. Atrial fibrillation-a complex polygenetic disease. Eur J Hum Genet. 2021;29(7):1051–1060. PMID: 33279945; PMCID: PMC8298566. doi:10.1038/s41431-020-00784-8
   PubMed Web of Science ®Google Scholar
• Lee SP, Ashley EA, Homburger J, et al. SHaRe investigators. incident atrial fibrillation is associated with myh7 sarcomeric gene variation in hypertrophic cardiomyopathy. Circ Heart Fail. 2018;11(9):e005191. PMID: 30354366. doi:10.1161/CIRCHEARTFAILURE.118.005191
   PubMed Web of Science ®Google Scholar
• Buchtele N, Schwameis M, Gilbert JC, Schörgenhofer C, Jilma B. Targeting von Willebrand factor in ischaemic stroke: focus on clinical evidence. Thromb Haemost. 2018;118(6):959–978. PMID: 29847840; PMCID: PMC6193403. doi:10.1055/s-0038-1648251
   PubMed Web of Science ®Google Scholar
• Wysokinski WE, Cohoon KP, Konik EA, et al. Effect of atrial fibrillation duration on plasma von Willebrand factor level. Eur J Haematol. 2017;99(6):569–576. PMID: 28952167; PMCID: PMC6310225. doi:10.1111/ejh.12975
   PubMed Web of Science ®Google Scholar
• Ding WY, Harrison S, Gupta D, Lip GYH, Lane DA. Stroke and bleeding risk assessments in patients with atrial fibrillation: concepts and controversies. Front Med. 2020;7:54. PMID: 32154260; PMCID: PMC7047213. doi:10.3389/fmed.2020.00054
   Web of Science ®Google Scholar
• Gairolla J, Ahluwalia J, Khullar M, et al. Clopidogrel response in ischemic stroke patients: is polymorphism or gender more important? Results of the CRISP study. J Clin Neurosci. 2020;76:81–86. PMID: 32317191. doi:10.1016/j.jocn.2020.04.038
   PubMed Web of Science ®Google Scholar
• Al-Eitan LN, Almasri AY, Khasawneh RH. Impact of CYP2C9 and VKORC1 polymorphisms on warfarin sensitivity and responsiveness in Jordanian cardiovascular patients during the initiation therapy. Genes. 2018;9(12):578. PMID: 30486437; PMCID: PMC6316567. doi:10.3390/genes9120578
   PubMed Web of Science ®Google Scholar
• Jorgensen AL, FitzGerald RJ, Oyee J, Pirmohamed M, Williamson PR. Influence of CYP2C9 and VKORC1 on patient response to warfarin: a systematic review and meta-analysis. PLoS One. 2012;7(8):e44064. PMID: 22952875; PMCID: PMC3430615. doi:10.1371/journal.pone.0044064
   PubMed Web of Science ®Google Scholar
• Arboix A, García-Eroles L, Massons J, Oliveres M, Targa C. Lacunar infarcts in patients aged 85 years and older. Acta Neurol Scand. 2000;101(1):25–29. PMID: 10660148. doi:10.1034/j.1600-0404.2000.00005.x
   PubMed Web of Science ®Google Scholar
• Chung H, Lee JM. Left atrial remodeling and thromboembolic risk in patients with atrial fibrillation. Int J Heart Fail. 2022;4(1):26–28. PMID: 36262196; PMCID: PMC9383338. doi:10.36628/ijhf.2022.0006
   PubMedGoogle Scholar
• Sahin T, Acar E, Celikyurt U, et al. Relation of hs-CRP and BNP levels with the atrial spontaneous echo contrast and thrombi in permanent atrial fibrillation patients with different etiologies. Med Sci Monit. 2012;18(2):CR78–87. PMID: 22293881; PMCID: PMC3560580. doi:10.12659/msm.882461
   PubMed Web of Science ®Google Scholar
• Christophersen IE, Rienstra M, Roselli C, et al. Large-scale analyses of common and rare variants identify 12 new loci associated with atrial fibrillation. Nat Genet. 2017;49(6):946–952. PMID: 28416818; PMCID: PMC5585859. doi:10.1038/ng.3843
   PubMed Web of Science ®Google Scholar
• Jansen HJ, Bohne LJ, Gillis AM, Rose RA. Atrial remodeling and atrial fibrillation in acquired forms of cardiovascular disease. Heart Rhythm. 2020;1(2):147–159. PMID: 34113869; PMCID: PMC8183954. doi:10.1016/j.hroo.2020.05.002
   Web of Science ®Google Scholar
• Chen YC, Voskoboinik A, Gerche A, Marwick TH, McMullen JR. Prevention of pathological atrial remodeling and atrial fibrillation: JACC state-of-the-art review. J Am Coll Cardiol. 2021;77(22):2846–2864. PMID: 34082914. doi:10.1016/j.jacc.2021.04.012
   PubMed Web of Science ®Google Scholar
• Jumeau C, Rupin A, Chieng-Yane P, et al. Direct thrombin inhibitors prevent left atrial remodeling associated with heart failure in rats. JACC Basic Transl Sci. 2016;1(5):328–339. PMID: 27642643; PMCID: PMC5012373. doi:10.1016/j.jacbts.2016.05.002
   PubMedGoogle Scholar
• Marott SC, Nordestgaard BG, Zacho J, et al. Does elevated C-reactive protein increase atrial fibrillation risk? A Mendelian randomization of 47,000 individuals from the general population. J Am Coll Cardiol. 2010;56(10):789–795. PMID: 20797493. doi:10.1016/j.jacc.2010.02.066
   PubMed Web of Science ®Google Scholar
• Fu T, Chen M, Xu L, et al. Association of the MYH6 gene polymorphism with the risk of atrial fibrillation and warfarin anticoagulation therapy. Genet Test Mol Biomarkers. 2021;25(9):590–599. PMID: 34515533. doi:10.1089/gtmb.2021.0025
   PubMed Web of Science ®Google Scholar